OAK TREE MEDICAL SYSTEMS INC
8-K/A, 1997-06-20
HEALTH SERVICES
Previous: PRICE T ROWE CALIFORNIA TAX FREE INCOME TRUST, 485BPOS, 1997-06-20
Next: CALIFORNIA MICRO DEVICES CORP, DEFA14A, 1997-06-20



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                    FORM 8-K/A

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934




Date of Report (Date of earliest event reported)      April 29, 1997



                         OAK TREE MEDICAL SYSTEMS, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


             Delaware                    0-16206                02-0401674
- --------------------------------------------------------------------------------
  (State or other jurisdiction         (Commission            (IRS Employer
         of incorporation)             File Number)         Identification No.)



           163-03 Horace Harding Expressway, Flushing, New York       11365
- --------------------------------------------------------------------------------
               (Address of principal executive offices)            (Zip Code)


Registrant's telephone number, including area code      (718) 961-5224



- --------------------------------------------------------------------------------
       (Former  name or former  address,  if changed  since last report.)







                                     Page 1


<PAGE>


ITEM 4.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT

(a)      Previous independent accountants

          (i)  On April 29, 1997 Oak Tree Medical Systems,  Inc. (the "Company")
               was  notified by the firm of Simon  Krowitz  Bolin &  Associates,
               P.A.,   that  they  were   resigning   from  the   client-auditor
               relationship.

          (ii) The reports of Simon  Krowitz  Bolin &  Associates,  P.A., on the
               Company's financial statements for the two fiscal years ended May
               31, 1996  contained no adverse  opinion or  disclaimer of opinion
               and was not qualified or modified as to uncertainty,  audit scope
               or accounting principle.

          (iii)Subject to the  qualification  in the letter  from Simon  Krowitz
               Bolin & Associates,  P.A.,  attached as Exhibit 16, in connection
               with the audit of the Company's financial  statements for its two
               fiscal years ended May 31, 1996 and through April 29, 1997, there
               have been no disagreements with Simon Krowitz Bolin & Associates,
               P.A.,  on any  matter  of  accounting  principles  or  practices,
               financial  statement  disclosure or auditing  scope or procedure,
               which  disagreements if not resolved to the satisfaction of Simon
               Krowitz Bolin & Associates,  P.A., would have caused them to make
               reference thereto in their report on the financial statements for
               such fiscal years.

          (iv) Subject to the  qualification  in the letter  from Simon  Krowitz
               Bolin & Associates,  P.A., attached as Exhibit 16, during the two
               fiscal years ended May 31, 1996 and through  April 29, 1997,  the
               Company  was not  advised of any of the  matters  referred  to in
               Regulation S-B Item 304(a)(1)(iv)(B).

(b)      New independent accountants

          (i)  The Company has retained the  accounting  firm of Most Horowitz &
               Company,   LLP  as  independent   accountants  for  the  Company,
               effective June 6, 1997.


ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

(c)      Exhibits

16   Copy of letter from Simon Krowitz Bolin & Associates,  P.A., dated June 19,
     1997 addressed to the Securities and Exchange Commission


                                     Page 2


<PAGE>




                                   SIGNATURES


                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


                                            By:   /s/ Henry Dubbin
                                                  -------------------
                                                  Name:  Henry Dubbin
                                                  Title:    President


Date:  June 19, 1997



                                     Page 3







                                                                      EXHIBIT 16

                     SIMON KROWITZ BOLIN & ASSOCIATES, P.A.
                        11300 Rockville Pike, Suite 800
                              Rockville, MD 20852

June 19, 1997

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

Ladies and Gentlemen:

                  Re:      Oak Tree Medical Systems, Inc.

We have  read  Item 4 of the Form  8-K/A,  dated  June 19,  of Oak Tree  Medical
Systems, Inc. (the "Company") and are in agreement with the statements contained
in paragraph 4(a) therein, subject to the following qualification. Subsequent to
the  completion of our audit of the financial  statements of the Company for the
fiscal year ended May 31, 1996, we have not had significant involvement with the
Company or its accounting  practices and procedures.  However,  to the extent of
our limited  involvement  with the Company during the period from the completion
of our audit of the Company's financial statements for the fiscal year ended May
31, 1996 through  April 29, 1997,  we are in agreement  for such period with the
statements contained in paragraphs 4(a)(iii) and 4(a)(iv) of the Form 8-K/A.

Yours very truly, 

/s/ SIMON KROWITZ BOLIN & ASSOCIATES, P.A.
- ------------------------------------------




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission